Pages that link to "Q73313263"
Jump to navigation
Jump to search
The following pages link to Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy (Q73313263):
Displaying 50 items.
- Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes (Q24657150) (← links)
- Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells (Q26798131) (← links)
- The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy (Q27002339) (← links)
- The cell biology of disease: cellular mechanisms of cardiomyopathy. (Q27686758) (← links)
- Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes (Q28251448) (← links)
- Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy (Q28344111) (← links)
- Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy (Q28348531) (← links)
- Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy (Q28570951) (← links)
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system (Q28585033) (← links)
- Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers (Q28730121) (← links)
- Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration (Q33148719) (← links)
- How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance. (Q33741738) (← links)
- The molecular genetic basis for hypertrophic cardiomyopathy (Q33939892) (← links)
- Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy (Q33947464) (← links)
- Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy (Q33978845) (← links)
- Experimental therapies in hypertrophic cardiomyopathy (Q33997765) (← links)
- Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy (Q34008230) (← links)
- Molecular genetics and pathogenesis of hypertrophic cardiomyopathy (Q34021080) (← links)
- Genetic aspects of arrhythmias (Q34263609) (← links)
- Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations (Q34568089) (← links)
- Modifier genes for hypertrophic cardiomyopathy (Q34641881) (← links)
- The IL-33/ST2 pathway: therapeutic target and novel biomarker (Q34776884) (← links)
- Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion (Q35113389) (← links)
- Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy (Q35163739) (← links)
- Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study (Q35576188) (← links)
- Association between angiotensinogen M235T polymorphism and hypertrophic cardiomyopathy (Q35756376) (← links)
- Cardiac neurotransmission SPECT imaging. (Q35912361) (← links)
- Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease. (Q36691040) (← links)
- Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation (Q37410985) (← links)
- Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy. (Q37631139) (← links)
- Mechanical and energetic consequences of HCM-causing mutations (Q37766181) (← links)
- The genetic landscape of cardiomyopathy and its role in heart failure. (Q38343935) (← links)
- Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy (Q38605392) (← links)
- Using baculovirus/insect cell expressed recombinant actin to study the molecular pathogenesis of HCM caused by actin mutation A331P (Q38998926) (← links)
- Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders (Q39050554) (← links)
- Current insights into LMNA cardiomyopathies: Existing models and missing LINCs (Q39104972) (← links)
- Left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy treated with percutaneous alcohol septal ablation: an echocardiographic study (Q39386769) (← links)
- Update on hypertrophic cardiomyopathy (Q40833716) (← links)
- ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study). (Q41815143) (← links)
- Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy (Q42515078) (← links)
- Can an energy-deficient heart grow bigger and stronger? (Q42701279) (← links)
- On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture (Q42735759) (← links)
- To screen or not is not the question--it is when and how to screen (Q42748756) (← links)
- Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: Comparison with multislice CT (Q45841750) (← links)
- Mitochondrial tRNA glutamine variant in hypertrophic cardiomyopathy. (Q46246554) (← links)
- Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy (Q48020405) (← links)
- Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle (Q49923294) (← links)
- Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy. (Q50259289) (← links)
- From Teare to the present day: a fifty year odyssey in hypertrophic cardiomyopathy, a paradigm for the logic of the discovery process. (Q53121381) (← links)
- Assessment of left ventricular longitudinal regional myocardial systolic function by strain imaging echocardiography in patients with hypertrophic cardiomyopathy. (Q53538405) (← links)